The tale of David Kwiatkowski, a healthcare worker prosecuted for felony actions, is well known to veteran infection prevention practitioners. Employed as a roving radiology technician, Kwiatkowski had orchestrated a complex system of diverting drugs from the facilities he was affiliated with. His modus operandi included stealthily extracting vials of painkillers to self-administer the medication, and then mixing his own blood into the emptied vials that were subsequently dispensed to patients. This lapse of ethical conduct resulted in the nosocomial transmission of hepatitis C to at least 45 patients, with one mortality from the cohort reported. Presently, Kwiatkowski is serving a 39-year prison term.
Nonetheless, the case presented here is a stark reminder that healthcare facilities are not immune to drug diversion issues, emphasizing the critical need for infection prevention teams to persistently monitor for such activities. Drug diversion, no matter its form, invariably heightens the risk factors for inpatients contracting an infection and might induce an unanticipated outbreak. As healthcare settings commence investing significantly in comprehensive safeguards, potential diverters explore inventive tactics to bypass these countermeasures.
Several ingenious methods have been registered, such as the discovery of an opioid bag that was fully drained and punctured, stashed in an infusion lockbox that apparently seemed secure but could be accessed merely using a paperclip. It has been verified via lab testing that other lock mechanisms and ensured receptacles could equally be breached effortlessly. Furthermore, even highly comprehensive electronic locks with inbuilt auditing and tracking are not impervious to manipulations by skilled diverters.
Employing extensive surveillance and engendering awareness regarding drug diversion within healthcare organizations, infection preventionists can counteract potential outbreaks. A proactive, multidisciplinary Controlled Substance Diversion Prevention Program should be instigated as a primary standard in these settings. This would necessitate a synergistic collaboration between various disciplines to effectively deter, recognize, report, and address drug diversion events. Instituting an unwavering policy mandating real-time documentation of all discrepancies and establishing an efficient reporting platform that backs the staff voicing their concerns are also paramount.
James Davis, the Manager Infection Prevention & Control Services at ECRI Solutions, extensively elaborates on how infection prevention teams can adopt advanced methods like machine learning diversion monitoring and analytics to detect anomalies, physical surveillance measures, and meticulous audits. These strategies are critical components to ultimately breaking the chain of infection in healthcare settings.